# q05 rev 0 raw returns (tested_sha256 b5701f231afc934da7f55929d882f4794383305f4cbf0cf9f6ec05e38d6aed29)

Fresh agents dispatched 2026-10-05 by the caller (Claude Code, Opus 5.5) with only the workspace
root, their own packet path and the verbatim question (closed-book: question only). Returns are
copied verbatim from the task notifications.

## Blind solver A (blind-solver, packet solver-1)

answer: −0.3 percentage points. The full-year 2025 adjusted operating margin was about 23.2% (23.24%), against the most recent outlook of "approximately 23.5%".

confidence: high

path:
1. **Outlook history.** All dated outlooks for the 2025 adjusted operating margin:
   - D01 (Jan 22, 2025), line 372: "Abbott projects full-year 2025 adjusted operating margin to be 23.5% to 24.0% of sales."
   - D02 (Apr 16, 2025), line 226: the same 23.5% to 24.0% range.
   - D03 (Jul 17, 2025), line 349: "Abbott projects full-year 2025 adjusted operating margin to be approximately 23.5% of sales."
2. **No later update.** The guidance section of D04 (Oct 15, 2025, lines 337–341) only reaffirms organic sales growth and narrows adjusted EPS to "$5.12 to $5.18". It says nothing about operating margin. D07 (Jan 22, 2026) gives only 2026 guidance for sales growth and EPS. D05 (Exact Sciences deal), D06 (by-laws), D09 (court filing), D11 (litigation settlement), and D08/D10 (2026 quarterly releases) contain no 2025 margin outlook. The most recent outlook is therefore D03's approximately 23.5%.
3. **Actual for 2025.** D07 does not state a full-year adjusted operating margin, so I derived it from its 12M25 non-GAAP reconciliation (lines 563–565, confirmed in docs/abt_ex991_2026-01-22.txt lines 561–563):
   - "Gross Margin | 23,327 | 1,824 | 25,151"
   - "R&amp;D | 2,942 | (112) | 2,830"
   - "SG&amp;A | 12,332 | (312) | 12,020"
   - Net Sales "$44,328" (line 456)
   - Adjusted operating earnings = 25,151 − 2,830 − 12,020 = 10,301. As a cross-check, GAAP operating earnings of 8,053 + 1,824 + 112 + 312 also gives 10,301.
   - Margin = 10,301 / 44,328 = 23.238%, or 23.2%.
4. **Method check.** The same formula reproduces each quarterly margin Abbott printed:
   - Q1: (5,918 − 689 − 3,051) / 10,358 = 21.03%, printed "21.0 percent" (D02).
   - Q2: (6,346 − 705 − 3,090) / 11,142 = 22.90%, printed "22.9 percent" (D03).
   - Q3: (6,344 − 730 − 3,004) / 11,369 = 22.96%, printed "23.0 percent" (D04).
   - Q4 from D07: 6,543 − 706 − 2,875 = 2,962.
   - The four quarters add up to the full-year figures: 2,178 + 2,551 + 2,610 + 2,962 = 10,301, and sales of 10,358 + 11,142 + 11,369 + 11,459 = 44,328.
   - The implied 2024 adjusted margin is 9,295 / 41,950 = 22.16%. That fits D01's statement that the 23.5–24.0% range is "an increase of 150 basis points at the midpoint compared to 2024".
5. **Difference.** 23.238 − 23.5 = −0.262, which rounds to −0.3 percentage points. Using the rounded 23.2 gives the same result: 23.2 − 23.5 = −0.3.

minimal_documents: D03 + D07. D04 is needed only to show that the October 2025 guidance did not change the margin outlook. For the actual, the quarterly sum from D02, D03, D04 and D07 is an alternative, but D07 is required either way.

readings:
- If "most recent outlook" meant the earlier 23.5%–24.0% range from D01/D02, the answer would be −0.5 against the 23.75% midpoint, −0.3 against the low end, or −0.8 against the high end. That reading ignores D03's later update, so I don't think it is the right one.
- One could argue that D04's guidance implicitly reaffirmed the margin outlook, but D04 never mentions margin. Either way the latest margin figure is ~23.5%, so the answer stays −0.3.
- Including "Other (income) expense, net" in the margin would not fit Abbott's printed quarterly margins, so I rejected that reading.

gaps:
- No document in the packet states the full-year 2025 adjusted operating margin directly. It is derived, using a method that matches all three quarterly margins Abbott reported.
- The "approximately" in the outlook means it is a point estimate, not a range.
- I did not read D01, D02, D05, D08 or D10 in full, and only skimmed the openings of D06, D09 and D11. All eleven text files were searched for "operating margin", "margin", "operating earnings", "full-year 2025/12M25", "projects/guidance/outlook" and recast terms.
- There are no Dnn.layout.txt files or PDFs in this packet. The key D07 rows were checked against the source .txt in docs/.

contaminated: no

Files used are under D:\Dev\Docket\tasks\aq-00745\runs\q05-r0-v2-b5701f231afc934da7f55929d882f4794383305f4cbf0cf9f6ec05e38d6aed29\solver-1\:
- text\D03.txt
- text\D04.txt
- text\D07.txt
- docs\abt_ex991_2026-01-22.txt

## Blind solver B (blind-solver, packet solver-2)

**answer:** −0.3 percentage points. Abbott's full-year 2025 adjusted operating margin was about 23.2% of sales. Its most recent outlook for that margin was "approximately 23.5%", so the result came in 0.3 points below it.

**confidence:** high

**path:**
1. **Outlook history.** Packet text is in `D:\Dev\Docket\tasks\aq-00745\runs\q05-r0-v2-b5701f231afc934da7f55929d882f4794383305f4cbf0cf9f6ec05e38d6aed29\solver-2\text\`.
   - D01 (Jan 22, 2025), lines 39 and 372: "Abbott projects full-year 2025 adjusted operating margin to be 23.5% to 24.0% of sales…"
   - D02 (Apr 16, 2025), line 226: same 23.5% to 24.0% range.
   - D03 (Jul 17, 2025), guidance section, line 349: "Abbott projects full-year 2025 adjusted operating margin to be approximately 23.5% of sales." This is the most recent margin outlook.
   - D04 (Oct 15, 2025): the headline says "Reaffirms Full-Year Guidance", but the guidance section (line 339) covers only organic sales growth and EPS, with no margin figure.
   - D05 (Exact Sciences deal), D06 (bylaws) and D07's guidance section (2026 outlook only) contain no margin outlook. D08 to D11 come after the year closed.
2. **Full-year 2025 actual (D07, Jan 22, 2026).** The release never states the full-year adjusted operating margin, so I calculated it from the 12M25 non-GAAP table (lines 563–565):
   - "Gross Margin | 23,327 | 1,824 | 25,151"
   - "R&amp;D | 2,942 | (112) | 2,830"
   - "SG&amp;A | 12,332 | (312) | 12,020"
   - Net sales: "$44,328" (line 456).
   - Adjusted operating earnings = 25,151 − 2,830 − 12,020 = 10,301.
   - Cross-check: GAAP operating earnings of 8,053 (line 462) plus specified items (1,824 + 112 + 312 = 2,248) also gives 10,301. These rows match the original file `docs\abt_ex991_2026-01-22.txt`.
   - Margin = 10,301 / 44,328 = 23.238%, or 23.2%.
   - Cross-check by quarters: 9M25 from D04 (18,608 − 2,124 − 9,145 = 7,339) plus Q4 from D07 (6,543 − 706 − 2,875 = 2,962) = 10,301. Sales 32,869 + 11,459 = 44,328.
3. **Method check against Abbott's own stated margins.** The same formula reproduces each published quarterly figure:
   - Q3 (D04): (6,344 − 730 − 3,004) / 11,369 = 22.96%, matching the stated "adjusted operating margin of 23.0 percent". The GAAP figure, 2,057 / 11,369 = 18.1%, also matches.
   - Q1 (D02): (5,918 − 689 − 3,051) / 10,358 = 21.03%, matching the stated 21.0%.
   - Q2 (D03): (6,346 − 705 − 3,090) / 11,142 = 22.90%, matching the stated 22.9%.
   - The 2025 comparatives in D08 (1Q25) and D10 (2Q25 and 6M25) match the original releases exactly, so the 2025 figures were not restated.
4. **Difference.** 23.238 − 23.5 = −0.262, which rounds to −0.3 points. Using the rounded 23.2% gives the same −0.3.

**minimal_documents:** D03 and D07. D07 is the only source with Q4 and full-year 2025 data, so it cannot be replaced. D04 is the useful extra: it confirms the October update didn't change the margin outlook and lets you check the method against its stated 23.0%. D01 or D02 can't stand in for D03 because their figure (23.5% to 24.0%) isn't the latest.

**readings:**
- **Primary:** actual minus the latest outlook (D03, about 23.5%) = −0.3 points.
- **D04's "reaffirms full-year guidance" as the latest outlook:** it carries no margin figure, so the standing number is still D03's 23.5%, giving −0.3.
- **Original January/April range:** against the 23.75% midpoint the gap is −0.5; against the 24.0% top it is −0.8. Against the 23.5% bottom it is −0.3. These are earlier outlooks, not the most recent one.
- **Opposite subtraction (outlook minus actual):** +0.3. The question's "give the sign" points to actual minus outlook, which is −0.3.
- **GAAP margin (8,053 / 44,328 = 18.2%):** not comparable, because the outlook was for the adjusted margin.

**gaps:**
- No document states the full-year 2025 adjusted operating margin directly. It is calculated, using the same method that reproduces Abbott's published quarterly margins.
- "Approximately 23.5%" is a hedged point estimate, not a range.
- Coverage: I read D07 and D11 in full and the relevant sections of D03, D04 and D05. D01, D02, D06, D08, D09 and D10 were checked by targeted searches (margin, guidance, outlook, and the statement and reconciliation rows) plus partial reads, not read end to end.
- The sources are text files, so there were no PDF pages to inspect. I did not open the packet's `question.txt`.

**contaminated:** no

## Closed-book solver (question only, no tools used)

answer: +0.1 percentage points (best guess: about 23.6% actual against an outlook of about 23.5%)

confidence: low

basis: I'm recalling this from memory and couldn't check it. Abbott's January 2025 outlook was an adjusted operating margin of about 23.5% to 24% of sales. I don't clearly remember the exact figure in its last update (October 2025) or the exact full-year result. A rough rebuild from full-year adjusted EPS of $5.15 and sales of about $44.3B puts the margin near 23.6–23.9%. Fourth-quarter EPS matched guidance even though sales missed, which points to a margin at or slightly above the outlook. The sign and size of the gap are uncertain.

contaminated: no

## Shortcut auditor (shortcut-auditor, packet shortcut)

answer: **−0.3 percentage points.** Abbott's full-year 2025 adjusted operating margin was about 23.2% (23.24%), against an outlook of "approximately 23.5%", so it came in 0.3 points below.

verdict: clear

shortest_path:
1. **Outlook (D03, Q2 2025 release dated July 17, 2025, guidance section, line 349):** "Abbott projects full-year 2025 adjusted operating margin to be approximately 23.5% of sales."
   - Earlier outlooks were a range: D01 (Jan 22, 2025) and D02 (Apr 16, 2025) both say "23.5% to 24.0% of sales."
   - The later Q3 release (D04, Oct 15, 2025, lines 337–341) reaffirms only the sales growth and EPS guidance. It gives no margin outlook, so D03's 23.5% is the most recent figure.
2. **Actual result (D07, full-year 2025 release dated Jan 22, 2026):** the release never states the margin, so it has to be calculated from the 12M25 non-GAAP reconciliation table (lines 563–565, net sales at line 456).
   - Adjusted gross margin 25,151 − adjusted R&amp;D 2,830 − adjusted SG&amp;A 12,020 = 10,301 ($M).
   - Cross-check: GAAP operating earnings 8,053 + specified items (1,824 + 112 + 312) = 10,301.
   - A second cross-check also gives 10,301: D04's nine-month adjusted figure (18,608 − 2,124 − 9,145 = 7,339) plus D07's Q4 figure (6,543 − 706 − 2,875 = 2,962).
   - Margin: 10,301 / 44,328 = 23.24%.
3. **Method check:** this calculation reproduces the margins Abbott itself stated.
   - Q3 2025: (6,344 − 730 − 3,004) / 11,369 = 22.96%, stated as 23.0%.
   - Q2 2025: (6,346 − 705 − 3,090) / 11,142 = 22.90%, stated as 22.9%.
4. **Difference:** 23.24 − 23.5 = −0.26, which rounds to −0.3. Rounding first (23.2 − 23.5) gives the same −0.3.

sufficient_documents:
- D03 (outlook) plus D07 (actual), with D04 needed to confirm no later margin outlook.
- Alternatives for the actual: D04's nine-month figures plus D07's Q4 figures give the same numerator. D08 and D10 repeat FY2025 sales of $44.328 billion but have no operating figures.
- No single document gives the answer, and the question's wording doesn't give it away. It's a simple two-document route plus a modest calculation, which is a difficulty risk rather than a shortcut.

searches:
- Terms searched across all 11 text files: "operating margin", "margin", "projects|outlook|guidance|forecast", and "full-year 2025|12M25|in 2025".
- Read in full: the manifest and D07.
- Read in part: D03 and D04 (highlights, guidance and reconciliation tables) and the opening sections of D05, D06, D08, D09 and D11.
- What the other documents are: D05 is the Exact Sciences acquisition release (mentions only gross margin). D06 is the corporate by-laws. D09 is a derivative-litigation settlement notice. D11 is an infant-formula litigation release; its only "margin" hit is the word "marginal". D08 and D10 are the 2026 quarterly releases, with 2026 guidance only.
- I spot-checked the key D07 figures (25,151 / 2,830 / 12,020 / 44,328 / 8,053) in the original source file and they match the text version.

readings/gaps:
- **Other readings:**
  - Measured against the earlier 23.5%–24.0% range midpoint (23.75%), the answer would be −0.5, or −0.8 against its high end. Both are rejected because D03's later point estimate supersedes them, and the question's singular "figure" fits D03.
  - Using the wrong measure changes the answer: GAAP operating margin of 18.2% (8,053 / 44,328) would give −5.3, and adjusted pre-tax margin of 24.3% (10,762 / 44,328) would give +0.8.
  - Someone could read D04's silence as dropping the margin outlook. The most recent stated figure is still 23.5%.
- **Gaps:** D01, D02, D05, D09, D10 and D11 were covered by search rather than read line by line, and the by-laws (D06) were skipped as irrelevant. No extraction gaps were found. I did not open the packet's question.txt.

Relevant files:
- D:\Dev\Docket\tasks\aq-00745\runs\q05-r0-v2-b5701f231afc934da7f55929d882f4794383305f4cbf0cf9f6ec05e38d6aed29\shortcut\text\D03.txt
- D:\Dev\Docket\tasks\aq-00745\runs\q05-r0-v2-b5701f231afc934da7f55929d882f4794383305f4cbf0cf9f6ec05e38d6aed29\shortcut\text\D04.txt
- D:\Dev\Docket\tasks\aq-00745\runs\q05-r0-v2-b5701f231afc934da7f55929d882f4794383305f4cbf0cf9f6ec05e38d6aed29\shortcut\text\D07.txt
- D:\Dev\Docket\tasks\aq-00745\runs\q05-r0-v2-b5701f231afc934da7f55929d882f4794383305f4cbf0cf9f6ec05e38d6aed29\shortcut\docs\abt_ex991_2026-01-22.txt
